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Background: Complex healthcare interventions consist of multiple components which may vary in trials conducted
in different populations and contexts. Pooling evidence from trials in a systematic review is challenging because it
is unclear which components are needed for effectiveness. The potential is recognised for using recipients’ views to
explore why some complex interventions are effective and others are not. Methods to maximise this potential are
poorly developed.
Methods: We used a novel approach to explore how patients’ views may explain the disparity in effectiveness of
complex interventions. We used qualitative comparative analysis to explore agreement between qualitative
syntheses of data on patients’ views and evidence from trialed interventions to increase adherence to treatments.
We first populated data matrices to reflect whether the content of each trialed intervention could be matched with
suggestions arising from patients’ views. We then used qualitative comparative analysis software to identify, by a
process of elimination, the smallest number of configurations (patterns) of components that corresponded with
patients’ suggestions and accounted for whether each intervention was effective or ineffective.
Results: We found suggestions by patients were poorly represented in interventions. Qualitative comparative
analysis identified particular combinations of components corresponding with patients’ suggestions and with
whether an intervention was effective or ineffective. Six patterns were identified for an effective and four for an
ineffective intervention. Two types of patterns arose for the effective interventions, one being didactic (providing
clear information or instruction) and the other interactive (focusing on personal risk factors).
Conclusions: Our analysis highlights how data on patients’ views has the potential to identify key components
across trials of complex interventions or inform the content of new interventions to be trialed.
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Systematic reviews of randomised controlled trial (RCTs)
are invaluable in combining evidence on effectiveness.
Their interpretation is most straightforward in drug
therapies. However, interpretation of the effectiveness of
more complex interventions is challenging as the inter-
ventions may consist of several components that vary
across trials but are assumed to contribute to the effect.
Based on reasons of practicality or personal choice pol-
icy makers and planners may then select one of these
varying interventions. They may also pick certain com-
ponents contained in one or more of these interventions.
New approaches are being sought to increase our under-
standing of how healthcare interventions exert their ef-
fects. These may involve asking trialists to identify the
common components of their effective interventions, for
example in relation to stroke care units [1]. They may
also, based on expert consultation using consensus me-
thods and literature review, involve developing taxo-
nomy to classify and describe effective interventions [2].
Or they may involve seeking to identify mechanisms
through which effects of the intervention are achieved.
For example, behaviour change theory might be applied
to trials identified in a systematic review of ‘audit and
feedback’ interventions [3].
Another way is to use recipients’ perspectives, experi-
ences or opinions on the potential suitability and utility
of an intervention. Recipients’ views are clearly import-
ant, particularly for interventions that require their ac-
tive participation. Innovative approaches to using such
information are being explored, for instance drawing on
qualitative evidence on recipients’ (usually patients’)
views to inform effectiveness evidence from systematic
reviews of trials [4]. The Cochrane Handbook on Sys-
tematic Reviews lists various ways qualitative evidence
can be used [5]. These include (but are not limited to)
helping to define the research question and helping to
ensure the review includes important outcomes. Another
way is to supplement reviews by synthesising qualita-
tive evidence within a stand-alone, but complementary,
quantitative review to address questions on aspects other
than effectiveness. In this way it is possible to examine
whether interventions that address patients’ priorities
might be more effective than those that do not. If this is
shown to be the case, it may be possible to identify com-
ponents that may have more or less influence on out-
comes. However, such considerations are constrained by
the quality, accuracy and extent of descriptions of the
intervention in papers reporting the results of trials
[6,7]. Sometimes, there may be no clear description of
the intervention beyond a basic statement, for example
what telephone counseling or psychosocial care involved
[7]. In addition, it remains unclear exactly how best to
bring together within a systematic review the differenttypes of evidence (qualitative and quantitative). More-
over, linking qualitative and quantitative evidence may
be hampered by the usual custom of publishing different
kinds of evidence in separate journals.
In earlier research we used evidence from trials of a
complex intervention in which content of the interven-
tion was reported and whose overall effect was unclear
[8]. This we combined with evidence from a review of
qualitative studies (often referred to as a qualitative evi-
dence synthesis (QES)). We used a data matrix table to
align the evidence from the QES of patients’ views with
the evidence from a Cochrane systematic review of trials.
This allowed visual exploration of correspondence be-
tween (i) suggestions on intervention content derived
from the QES, and (ii) components of interventions in
effective and ineffective trials. We reported that compo-
nents of effective interventions corresponded more often
than those of ineffective interventions with patients’ pri-
orities derived from the QES. The potential of combin-
ing mixed evidence in this way is recognised [9].
Qualitative comparative analysis (QCA) is an analytical
approach and a set of techniques [10]. It is recognised in
social sciences as an innovation in mixed methods re-
search [11,12], and it has been found to be applicable to
the evaluation of complex public health interventions
[13]. QCA has as yet untested potential for use in inte-
grating reviews of qualitative and quantitative health evi-
dence [14]. The potential of QCA in the analysis of a
systematic review of complex interventions is seen in:
(1) its usefulness in small datasets (where statistical ana-
lysis can be limited), and (2) how it seeks to explain a
given outcome by identifying multiple pathways of puta-
tive causal factors. This may be viewed as analogous
with locating different recipes to make a cake. This
approach is relevant to the analysis of complex inter-
ventions where the focus should include the differing
circumstances, mechanisms and patterns through which
an intervention may fit together to exert its effect. In
this paper, we report our research using a systematic re-
view with a larger number of quality trials than in our
earlier work [8]. This allowed us to test the use of QCA
in understanding how to integrate qualitative and quan-
titative review evidence. In doing so, we aimed to iden-
tify more information than would be possible by visual
inspection.
In this worked example of combining mixed evidence
from systematic reviews on interventions to improve ad-
herence to drug therapy, we used QCA to explore how
qualitative evidence might explain the variability in ef-
fectiveness of complex interventions.
The objective was to identify matches between pa-
tients’ views and components of interventions and see
whether these matches were associated with the effec-
tiveness of interventions.
Candy et al. Trials 2013, 14:179 Page 3 of 10
http://www.trialsjournal.com/content/14/1/179Methods
Data
We first identified a systematic review of trials. We
searched specifically for a Cochrane systematic review
because these reviews are performed to internationally
agreed standards. We sought a review on chronic disease
self-management because it requires long-term commit-
ment by patients, whose views are therefore pertinent.
This review needed to involve a sufficient number of tri-
als to require an analytical tool to aid quantitative ana-
lysis (at least five trials) [15]. It also needed to include
trials that differed in intervention effect, and in which
the content of the intervention was described in suffi-
cient detail to understand how the intervention might be
operationalised in practice. We chose a review of inter-
ventions to promote adherence to drug therapy for a
range of conditions [16], because it fulfilled our criteria
and because we were aware from earlier work that a
complementary QES was available [8]. This QES by
Vervoort and colleagues explored evidence about HIV/
AIDS patients’ views on their disease self-management
[17]. We purposively sought additional QES for adhe-
rence to therapy in other common chronic diseases
reported in the trials included in the Cochrane review
(such as diabetes, asthma and depression) [16]. We
searched three large citation databases from 1999 to
2009; Medline, Psyinfo and Cinahl. We used terms relat-
ing to the diseases of participants in the trials and terms
describing a QES. Details of the search strings for identi-
fying QES are listed in Additional file 1. As the focus of
this study was on the exploratory use of QCA, our
search for QES was not exhaustive. We were not
concerned that we may not identify a QES in relation to
patients’ views on all diseases relevant to the Cochrane
review. This is because our earlier research suggested
that such evidence was not necessarily disease-specific
[8]. We identified three relevant QES [18-20]. They were
selected on the basis that (1) they explored patients’
views on living or managing their chronic disease, (2)
they were of sufficient methodological quality [21], and
(3) their findings were or could be translated into
suggestions for strategies to promote adherence to ther-
apy for a range of long-term conditions. The QES by
Vervoort et al. identified earlier thematically analysed
evidence from 18 studies on patients views on adherence
to HIV therapy [17]; of the others, Campbell et al.
synthesised evidence in a meta-ethnographic review
from 10 studies on patients’ views on diabetes inclu-
ding how they managed their disease [18], the QES by
Malpass and colleagues was a meta-ethnography of 16
studies on patients’ experience of taking antidepressants
[19] and the other, the QES by Schlomann and col-
leagues, analysed thematically 11 studies on lay beliefs
about high blood pressure [20].From each QES one author (BC) extracted data on
findings relating to promoting adherence. They were
listed as individual strategies to promote adherence. The
extraction sheet used to extract data from the QES is de-
tailed in Additional file 2. Another author (LJ) checked
the list for completeness against the QES. The final list
was discussed with all authors at project meetings. From
the QES by Vervoort et al. we had already derived 22
suggested strategies [17]. The additional three QES pro-
vided 17 suggestions; of these, 14 were similar to those
generated from the QES by Vervoort et al. [17]. They fo-
cused on the same issues, for example in the QES on be-
liefs about high blood pressure, the authors derived as
an implication for practice that: ‘The therapeutic content
of that consultation is in part dependent on the GP’s un-
derstanding of the patients’ beliefs and views regarding
medication use’ [20]. This is similar to two suggestions
from the QES by Vervoort et al., specifically the more
general suggestion ‘Interventionists should enquire into
possible factors influencing each individual patient be-
fore starting treatment’ and the more focused suggestion
advising that ‘ambivalence towards medications should
be discussed’ [17]. In total, we listed 25 different ways of
promoting adherence. These are listed in Additional file 2:
Table S2.
We did not set methodological quality criteria for se-
lection of the review of trials as we assumed a published
Cochrane review would have already undergone rigorous
checking. However our earlier research suggested the
need to restrict trials by quality [8]. Therefore, we only
used the 21 trials that were assessed by the Cochrane
reviewers as fulfilling their quality criteria [22-42].
This was based on the key recommendation by the
Cochrane Collaboration, which was assessment of whe-
ther randomization was concealed [43]. The 21 trialed
interventions in our chosen Cochrane review varied
in how they aimed to promote adherence, for exam-
ple by providing more instruction, increasing conve-
nience of care, and providing psychological therapy
and/or group meetings.
Eleven of the trials were deemed by the Cochrane re-
viewers as effective in promoting adherence. This judg-
ment was based on whether the P value was significant
at the <0.05 level. On this basis we assigned a binary
outcome for each of the trials; ‘1’ if the trial was effective
and ‘0’ if ineffective. We were aware of the weakness of
using the P value as indicating effect, but additional in-
formation was limited. We could not use the preferred
option of effect size, because some trials did not report
this. Trials also assessed adherence differently, including
pill counts, self-report of adherence and pharmacist
records. The data extraction form for whether the in-
tervention was found to be effective is provided in
Additional file 2: Table S3.
‘Raw data’
Table of correspondence between 21 trialed 
interventions and 25 suggestions on content
Data preparation
Table of correspondence between 21 trialed 
interventions and 9 suggestions on content
Analysis 0ne Analysis Two
Exploration for Exploration for
patterns in the data in patterns in the data in
relation to effective relation to ineffective
interventions interventions
Figure 1 Flow chart for QCA analysis.
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We scored the contents of each intervention against the
25 suggested strategies derived from the QES. The infor-
mation on intervention content was key to our analysis.
Details of the interventions were sought from the ori-
ginal trial papers in which they were more extensively
reported. However, to ensure detail was sufficient for
our analysis, on reading the papers we applied two cri-
teria: (1) that more than two sentences were devoted to
describing the intervention content, and (2) that compo-
nents were described in detail [44]. What we meant by
detail was that there was more than a brief statement.
For instance, if the intervention was described as educa-
tional, then there needed to be detail on more than one
aspect of that educational approach. All intervention de-
scriptions met these criteria. Intervention descriptions
ranged in length from three sentences to twenty-eight
(the median in interventions found ineffective was six to
eight, and in effective was nine to ten). The description
for each trial intervention is provided in Additional file 3.
We used binary scoring; 1 = suggestion corresponded with
an intervention component, 0 = no correspondence. We
were aware that binary scoring could reduce the potential
information available. However, a more graded scoring
was for many suggestions not relevant, and if adopted
might have increased subjectivity in scoring. To enhance
standardisation and clarity, scoring guidelines (available
from authors) were devised and tested by independent
researchers. We populated a data matrix table for each
intervention with all the conjoined data and where the
intervention was effective. We report an analysis of the re-
lationships created in this table between the qualitative
and quantitative data.
Qualitative comparative analysis: the approach
To analyse the relationships created we used QCA [10].
QCA uses Boolean algebra. It is grounded in set-theoretic
relationships. This allows in the analysis all logically pos-
sible combinations of factors to be examined systematic-
ally in relation to the outcome: as in which ingredients
work together to make a cake. In our worked example,
QCA identifies across interventions all parsimonious pat-
terns of components that match patients’ views and result
in the intervention being effective. Here, parsimonious is
the smallest number of patterns of components (in the
dataset) that account for the intervention effect. This is
not to imply that an intervention is effective because of
the match with patients’ views but rather this congruence
might moderate its effectiveness.
QCA is case-orientated in that it seeks to explain the
outcome in terms of ‘pathways of components’ per trialed
intervention: as in which ingredients per cake were essen-
tial or necessary. This differs from a conventional statistical
approach, which would average the effect simultaneouslyacross all interventions. Therefore, in this example QCA
presents ‘key’ components per individual intervention.
‘Key’ in these data means those found to be the simplest
explanation (in the data provided) for the results.
Qualitative comparative analysis: the technique
To explore patterns in the relationships between the
data we used specific QCA analysis software [45]. The
software explored these data using Boolean algorithms.
This involved pair-wise comparison between interven-
tions to establish commonalities in the way the relation-
ships created (between the qualitative and quantitative
evidence) combined together in effective and ineffective
interventions. To do this the QCA software reduced the
data presented per intervention by only retaining those
data found to produce the outcome.
The analytical process has several stages; these are
charted in Figure 1. QCA involves analysis of cases, factors
and outcomes. In these data cases are the interventions
and outcome is whether or not the intervention under
trial conditions was found to be effective. Factors were the
relationships created between the suggested strategies and
the intervention content, that is whether or not the inter-
vention contained content that corresponded with pa-
tients’ views on how to promote adherence. QCA is
limited in the number of factors that can be included in
analysis. This is because cases must be aligned with factors
and this process can quickly become unwieldy. This is due
to the large number of possible combinations of factors
that are created. For two factors there will be four possible
configurations, for nine factors there will be 512 and so
on. Thus the number of possible configurations of factors
can quickly exceed the number of cases. On examining
published papers using QCA, we found that none used
more than 10 factors. In our worked example, we reduced
our number of suggested strategies from 25 by first not
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of the trialed interventions. We then combined those that
had some overlap in aim. This resulted in nine suggested
strategies. See Table 1.
QCA analysis is unidirectional; therefore we undertook
two analyses, one for effective and a second for ineffec-
tive interventions.
Analysis models
QCA uses three analysis models to summarise fin-
dings [10]. These are the complex, intermediate and the
parsimonious. We present the parsimonious model be-
cause, unlike the complex model, it fully utilises the math-
ematical approach by allowing inferences to be made on
unobserved cases. Inferences are based on the patterns
found between the data in the observed cases; the modelTable 1 Reducing for the purposes of qualitative comparative
First step. Excluding 10 factors that had been described in
three or fewer interventions:
1. Ackno
2. Paying
3. Discus
treatmen
4. Discus
5. Feedb
provided
6. In case
substanc
7. To dev
8. To faci
9. To get
10. To of
Second step. Combining factors that had some similarity in
aim:
11. Enqu
became
13. Discu
became
15. Point
and 16. E
‘emphasi
17. Clear
to patien
19. Acqu
how use
became
Final list of factors used in QCA (this is the four remaining
factors (22 to 25) and the five combined factors (a to e)
22. Discu
23. Emph
drug.
24. Enhan
25. Inform
a. A focu
b. An exp
c. Empha
d. Clear o
e. A focumakes assumptions on the outcome of the combinations
of factors not taken up in the unobserved cases. In the
complex model, no inferences are made on unobserved
cases. In a sensitivity analysis, we also ran the analysis
using this model. In the intermediate model, the researcher
makes assumptions on unobserved cases by testing the ef-
fect in one selected direction only (as in a one-tailed statis-
tical test). We did not use this model as a suggested
strategy could have potentially led to a negative outcome.
Sensitivity analysis
Our approach involved subjective decisions that could
impact on our findings. Therefore, we tested the under-
lying assumptions in our model by:
 reducing data by (1) excluding cases (interventions)
if they did not correspond with any of theanalysis (QCA) the number of factors to below 10
wledging within the intervention that adherence is dynamic.
attention to possible negative social circumstances.
sing whether secrecy of disclosing condition is threatened by taking
t.
sing the seriousness of the disease.
ack about positive reactions of the body to treatment should be
.
s of depression, this should be treated before starting therapy;
e misuse should be managed as a first priority.
elop a trusting relationship with the patient.
litate to learn to trust in oneself.
patients to describe their own behaviour.
fer good medical follow-up.
ire into personal risks factors, and 12. Use insight on personal risk factors
‘a focus on personal risk factors’;
ss ambivalence to medicine, and 14. Discuss acceptance of disease
‘an exploration of attitudes to drug and/or disease’;
ing out the value of treatment to a patient’s life enhances motivation,
xplain the relationship between adherence and disease became
s on the value of adherence’;
instructions on how to take medication, and 18. Information appropriate
t’s understanding became ‘clear or appropriate information’;
ire insight into a patient’s social support systems, 20. Counsel patient on
social support, and 21. Social support has to be substantial and practical
‘a focus on improving social support’.
ss circumstances that lead to forgetting to take treatment.
asise that experiencing no symptoms does not mean to stop taking the
ce convenience of taking the drug.
ation on side effects.
s on personal risk factors.
loration of attitudes to drug and/or disease.
sis on the value of adherence.
r appropriate information.
s on improving social support.
Table 2 Pathways identified to effective and ineffective
interventions
Effective
interventions
The configuration most commonly associated with
effectiveness (found in eight trials) involved one
factor: ‘a focus on personal risk factors’ (pathway 1:
[15-17,19,20,23,26,27]). Other configurations each
involved the presence of one factor, and the
absence of other factors. One configuration involved
‘explaining the value of adherence’ with the
absence of:
(i) ‘Discuss circumstances that lead to forgetting to
take treatment’ and ‘a focus on improving social
support’ (pathway 2: [24,25,29]).
Or the absence of:
(i) ‘Discussion relating to not stopping the
medication if there are no symptoms’ and
‘improving social support’ (pathway 3: [16,18,22,29]).
The other configurations involved ‘provision of
clear/appropriate information on how to take
medication’, with the absence of:
(i) ‘Exploration of attitudes to therapy/disease’ and
‘discussion relating to not stopping taking
medication if there are no symptoms’ (pathway 4:
[17,18,22,29]).
Or the absence of:
(ii) ‘Discussion relating to missing a drug’ and
‘discussion relating to not stopping taking
medication if there are no symptoms’ (pathway 5:
[24,25,27,29]).
Or the absence of:
(iii) ‘Discussion relating to not stopping taking
medication if there are no symptoms’ and
‘improving social support’ (pathway 6: [17,18,22,29]).
Ineffective
interventions
All four configurations (pathways) for the ineffective
interventions included the absence of one factor: ‘
a focus on personal risk factors’. Two of the
configurations also involved the absence of either:
(i) ‘Information on side effects’ and ‘pointing out the
value of adherence’ (pathway 1: [31,33-35]).
or
(ii) ‘Pointing out the value of adherence’ and
‘provision of clear or appropriate information’
(pathway 2: [30,33-35]).
In the other two configurations the absence of ‘a
focus on personal risk factors’ also involved the
presence of either:
(i) ‘Discussion relating to missing a drug’ (pathway 3:
[28,30-32]). or
(ii) ‘Emphasis that experiencing no symptoms does
not mean stopping medication’ (pathway 4: [21,32]).
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suggestions because they did not enter the final
analysis model or were found in analysis to explain
the outcome by both their presence or their
absence;
 increasing the data by including all 67 trialed
interventions (irrespective of quality) in the
Cochrane review;
 analysing the data differently by (1) reporting the
results using the QCA complex model; and (2)
using (where appropriate) a graded scoring system
rather than binary to score agreement between
intervention components and suggestions.
Results
We found that suggestions by patients were poorly rep-
resented in interventions. In Additional file 4 this is il-
lustrated in a cell by a ‘–’. QCA identified six potential
pathways (configurations of components) to an effective
and four to an ineffective intervention. The configura-
tions are different per outcome. Each configuration is
represented in Additional file 4 by a different colour
shading, border or cell pattern.
Effective interventions
There were two types of patterns for the effective inter-
ventions; one involving the presence of one component
(pathway 1), and the others involving more components
of which some are shared between the configurations
(pathways 2 to 6).
The configuration most commonly associated with
effectiveness (found in eight trials) involved one com-
ponent: ‘a focus on personal risk factors’ (pathway 1:
[22-24,26,27,30,33,34]). Other configurations each in-
volved either the presence of ‘explaining the value of
adherence’ or ‘provision of clear/appropriate infor-
mation on how to take medication’, and the absence
of other components (Table 2 and Additional file 4:
Table S1).
The pathways correspond with two distinct approaches
to promoting adherence, one being interactive (‘a focus on
personal risk factors’) (pathway 1) and the other more di-
dactic (‘emphasizing clear or appropriate information’)
(pathways 2 to 6). Neither the interactive nor the didactic
approach was differently associated with the specific dis-
eases in the trial populations.
Ineffective interventions
All four configurations (pathways) for the ineffective
interventions included the absence of one component,
‘a focus on personal risk factors’. The configurations
also involved various combinations of other compo-
nents (Table 2 and Additional file 4: Table S2).Sensitivity analyses
There were sufficient data to undertake all proposed
sensitivity analyses. None of the analyses had dramatic-
ally different findings, in that most of the dominant pat-
terns per outcome remained. A common component, ‘a
focus on personal risk factors’, for an effective interven-
tion remained in most analyses. As before, the configu-
rations for ineffective interventions commonly remained
the mirror opposites of those found in the models for an
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produced more configurations. Some of these (particu-
larly when all trials irrespective of quality were included)
were conflicting, in that they included per outcome both
the presence and absence of certain factors.
Discussion
Main findings
We tested QCA as a way to combine QES evidence on
patients’ views with evidence from a systematic review
of trials of a complex intervention. We used as a worked
case example evidence on interventions to promote ad-
herence to long-term drug therapy. We found in general,
patients’ suggestions on what is important were poorly
represented in the interventions. Using QCA we found
that certain suggestions seemed to hold together in
particular patterns that corresponded to whether the
intervention was effective or not. Three influential com-
ponents were identified in the effective interventions,
while other components were influential through their
absence. It seemed that those that were influential by
their absence were those in which those providing the
intervention focused on negative influences on adher-
ence, such as ‘the need to take the drug continuously ir-
respective of symptoms’. The pattern of components
suggests two approaches to promoting adherence. One
involved adopting an interactive style focusing on per-
sonal risk factors. The other was a more didactic ap-
proach. This involved emphasising clear, appropriate
information including the value of adherence but with-
out discussing certain potentially challenging aspects,
such as discussion of attitudes to medication or disease,
missing doses or enhancing social support, or taking the
drug continuously irrespective of symptoms. Individual
patients may respond better to either the interactive or
didactic approach.
It is difficult to identify other research that has similar
overall findings, in part because of the novelty of this ap-
proach. However, what we found had face validity. In
particular, the correspondence between effective and in-
effective interventions was often mirror opposites. This
was best illustrated by the suggestion that the interven-
tion should focus on personal risk factors, which was
present in most of the effective interventions and absent
in all ineffective interventions. These findings generate
hypotheses about what may be more usefully included in
future interventions, which then need to be followed by
randomised controlled trials to generate evidence about
effectiveness.
Limitations and advantages
There are challenges to the use of QCA as used in this
study in the evaluation of interventions. These make in-
terpretation of our findings more difficult. First, prior toQCA analysis, selection and processing of the evidence
from source to our analysis involved the need for several
decisions. As the focus of this study was on the explora-
tory use of QCA, our search for QES was not exhaus-
tive. We used only controlled vocabulary and a limited
number of databases. This presupposes that there are
more QES beyond those located, from any further QES
there may be other ways to promote adherence. There
were several stages of synthesis, extraction and interpret-
ation, with only the final stages undertaken by us. For
the qualitative evidence this involved: (1) patients’ views
on living with and managing a disease being collected
and analysed in a large number of studies; (2) the fin-
dings from these studies being pooled in further quali-
tative analysis, which used different methodologies in
critiquing and analysing; and (3) these findings then be-
ing translated into suggestions for intervention compo-
nents. In the quantitative evidence, the method was
challenged by reliance on the completeness of inter-
vention descriptions. Complex interventions are often
poorly described in main trial papers and this is a
real limitation to any attempt (using QCA or another
method) to understand why variations in effectiveness
occur. The brevity of descriptions of the intervention
and the lack of agreement over what constitutes a
complete description make it problematic to assume that
particular aspects of an intervention were absent simply
because they were unreported. Another limitation in our
work is using a P value to decide whether or not an
intervention was effective or not. However, wherever
possible, we used robust approaches to reduce the risk
of bias, such as by setting quality criteria, and making
independent checks of steps undertaken during the
study.
In our use of QCA we also needed to make subjective
decisions that could have introduced error. However, we
undertook sensitivity analyses to test the consistency of
our findings. In QCA a limited number of factors can be
analysed and this restricted our exploration of hetero-
geneity of interventions to less than ten features. Addi-
tionally, within any one (QCA) analysis, the exploration
of an outcome can only be conducted in one direction
(either the outcome is effective or ineffective). A single
analysis cannot be used to quantify and compare head to
head the differences between the outcomes. The method
also does not incorporate a statistical (probability) meas-
ure of the precision of the relationships found in the
data, or the likelihood that they are simply chance find-
ings. However, the small dataset limits the use of con-
ventional statistics and thus alternative approaches are
needed. Finally, QCA is only of use in circumstances
where the trial evidence continues to result in equivocal
results. Thus not all interventions have the potential to
undergo this sort of analysis.
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dress a key challenge in trials of complex interventions,
namely understanding why some are effective and others
not. It is particularly useful where the pathways (as in
complex interventions) to success may differ across tri-
als. Using QCA to analyse complex healthcare inter-
ventions could identify several types of best practice;
that is, effective interventions that share similar key
components. Thereby planners and practitioners may be
informed by patient choice to select intervention compo-
nents for a type of best practice based on local conditions
and choice. This is with an understanding of which com-
ponents it may be more important to include.
QCA is under-explored and its usefulness in complex
intervention development is not established. This study
does not suggest that this approach may be useful in
every circumstance, or that QCA is more informative
than other approaches being considered. Moreover, there
is value in consulting patients directly in the develop-
ment of an intervention [46]. While the results of local
consultation apply to the specific setting, they also shed
light on implications of the intervention elsewhere and
the need for consideration of recipients’ views and beha-
viours. For instance, Atkins and colleagues [47] explored
patients’ experiences of a new intervention, aiming to
empower them to take more responsibility for the ma-
nagement of their tuberculosis. They found that the in-
tervention had achieved its aims but only in patients
internalising the intervention messages, not necessarily
resulting in an increase adherence.
This paper highlights the value of listening to patients’
views in order to understand disease management. In
the case of chronic disease, greater adherence seems to
be associated with a focus on personal risk factors, an
emphasis on the value of adherence, and the provision
of clear and appropriate information on how to adhere.
We have demonstrated the potential value of using
qualitative research to explain the varying effectiveness
of complex interventions. We call for more integrative
research in this area.
The usefulness of QCA should be tested by comparing
it with alternative approaches such as using more sub-
jective researcher judgments in exploring the same evi-
dence, or (dependent on data limitations) with other
analytical tools such as such as Bayesian statistics or re-
gression methods. The 10 factors (listed in Table 1) that
were mentioned in three or fewer interventions and
omitted from the analysis may deserve further attention
from primary research.
Conclusion
In this case study, we found that the application of QCA
enhanced our understanding of the effectiveness of com-
plex interventions.Additional files
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